This page shows the latest Clinolipid news and features for those working in and with pharma, biotech and healthcare.
FDA backs Clinolipid to alleviate shortage of drugs for people unable to eat or drink. . ... The US Food and Drug Administration (FDA) has approved Baxter's Clinolipid as an intravenous nutritional supplements for adult patients unable to eat or drink.
shutdown. For example, Baxter has secured approval for its Clinolipid intravenous nutritional supplement on Friday, while Discovery Labs has been given a green light for updated specifications for its Surfaxin (lucinactant)
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
imc provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including...